Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-032297
Filing Date
2024-10-28
Accepted
2024-10-28 16:17:14
Documents
5
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A rvph20241023_def14a.htm DEF 14A 490198
2 a01.jpg GRAPHIC 113678
3 a02.jpg GRAPHIC 93137
4 capn.jpg GRAPHIC 38729
5 comp.jpg GRAPHIC 39283
  Complete submission text file 0001437749-24-032297.txt   883640
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38634 | Film No.: 241401111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)